Predictors for early readmission in patients hospitalized with new onset pediatric lupus nephritis

Angel Ah Guerra1, Rouba Garro2, Courtney McCracken3

  • 1Department of Pediatrics, Division of Pediatric Allergy, Immunology and Rheumatology, 426490University of California Davis, Sacramento, CA, USA.

Lupus
|September 17, 2021
PubMed

Insights

Pediatric lupus nephritis readmissions occur in 17% of children within 30 days. Avoiding intravenous pulse methylprednisolone and albumin-assisted diuresis may reduce early pediatric lupus nephritis hospital readmissions.

Area of Science:

  • Pediatric Nephrology
  • Rheumatology
  • Hospital Readmission Research

Background:

  • Pediatric lupus nephritis (LN) is a severe manifestation of childhood-onset systemic lupus erythematosus.
  • Early hospital readmissions in pediatric LN can indicate suboptimal management and impact patient outcomes.
  • Understanding risk factors for 30-day readmissions is crucial for improving care transitions.

Purpose of the Study:

  • To determine the 30-day hospital readmission rate in children with new-onset lupus nephritis.
  • To identify risk factors associated with early readmissions in this vulnerable pediatric population.

Main Methods:

  • Retrospective analysis of 76 children hospitalized with new-onset lupus nephritis between 2008 and 2017.
  • Calculation of the 30-day hospital readmission rate.
  • Univariable and multivariable analyses to compare readmitted versus non-readmitted patients.

Main Results:

  • The 30-day readmission rate was 17.1%.
  • Factors associated with readmission included male gender, not receiving pulse steroids, diuretic treatment, albumin infusions, stage 2 hypertension, higher white blood cell count, non-ACE antihypertensive drugs, and NSAID use at discharge.
  • Multivariable analysis identified lack of intravenous pulse methylprednisolone (IVMP) and albumin-assisted diuresis for hypervolemia as significant predictors of readmission.

Conclusions:

  • Approximately 17% of children hospitalized for new-onset lupus nephritis experience readmission within 30 days.
  • Absence of IVMP and the need for albumin-assisted diuresis during initial hospitalization are key risk factors for early readmission in pediatric lupus nephritis.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
88
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
104
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
166
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
239
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
139